Literature DB >> 4171739

Urinary light-chain excretionin myeloma and other disorders--an evaluation of the Bence-Jones test.

F D Lindström, R C Williams, W R Swaim, E F Freier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4171739

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  8 in total

1.  Urinary light chain excretion in leukaemia and lymphoma.

Authors:  F D Lindström; R C Williams; A Theologides
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

2.  Clinical applications of immunofixation: a more sensitive technique for the detection of Bence Jones protein.

Authors:  J T Whicher; L Hawkins; J Higginson
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

3.  Kappa:lambda light chain ratio in IgG eluted from rheumatoid arthritis synovium.

Authors:  F D Lindström
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

4.  Intact and fragmented intracellular immunoglobulin in a case of non-secretory myeloma.

Authors:  J T Whicher; J D Davies; J A Grayburn
Journal:  J Clin Pathol       Date:  1975-01       Impact factor: 3.411

5.  Peptichemio induction therapy in myelomatosis.

Authors:  G Merlini; P G Gobbi; A Riccardi; G Riva; C Sardi; S Perugini
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Multiple myeloma. Clinical correlation of immunoglobulin changes with therapy. A report of 23 cases.

Authors:  C M Basch; E H Rosenbaum
Journal:  Calif Med       Date:  1969-01

7.  Anomalous urinary proteins in patients with serum M-components.

Authors:  W Pruzanski; M A Ogryzlo
Journal:  Can Med Assoc J       Date:  1971-04-03       Impact factor: 8.262

8.  Monoclonal immunoglobulin light chains in urine of patients with lymphoma.

Authors:  J Pierson; T Darley; G T Stevenson; M Virji
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.